Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Vericel Corp | a2221280zs-1a.htm |
| EX-5.1 - EX-5.1 - Vericel Corp | a2221280zex-5_1.htm |
| EX-23.1 - EX-23.1 - Vericel Corp | a2221280zex-23_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT AUDITORS
We hereby consent to the incorporation by reference in this Registration Statement on Amendment No. 1 to Form S-1 of Aastrom Biosciences, Inc. of our report dated May 29, 2014 relating to the Special Purpose Combined Financial Statements of the Cell Therapy and Regenerative Medicine Business (the "CTRM business"), a product portfolio of Sanofi, which appears in Aastrom Biosciences, Inc.'s Current Report on Form 8-K/A dated August 29, 2014. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
August 29, 2014
CONSENT OF INDEPENDENT AUDITORS